Reading this on a mobile device? Try our optimized mobile version here: http://r.smartbrief.com/resp/eauKCrsecrzvzrttCeLR

November 27, 2012
Sign upForwardArchive
News for the PBM Industry

  Featured Story 
  • Brand-name drugmakers cling to market share with costly copay coupons
    More pharmaceutical companies are issuing copay coupons as patents on brand-name drugs expire with few blockbuster candidates in the pipeline. The coupons may seem like a bargain to consumers, but they keep health care costs high because insurers' share of the cost is much higher than if the patient were taking a generic drug. A study last year by the Pharmaceutical Care Management Association found brand-name-drug copay coupons could increase prescription drug spending by $32 billion over the next 10 years. The Atlanta Journal-Constitution (11/27) LinkedInFacebookTwitterEmail this Story
  Legislative & Regulatory News 
  • Supreme Court allows ACA challenge to move forward
    The Supreme Court ruled that Liberty University's lawsuit challenging the Affordable Care Act may be reheard in a federal appellate court. The school says the law forces employers and the public to subsidize contraception and abortions in violation of First Amendment rights to religious freedom. The school might also claim that Congress exceeded its power in mandating that employers offer health insurance. Reuters (11/26) LinkedInFacebookTwitterEmail this Story
  • Budget negotiators consider raising Medicare eligibility age
    Gradually increasing the eligibility age for Medicare from 65 to 67 would reduce federal spending by about $148 billion and might increase revenue as more people stay in the workforce, according to the Congressional Budget Office. Seniors would have an easier time getting private insurance once the Affordable Care Act is fully implemented, proponents of the idea say. However, research indicates costs would be transferred to employers and federal subsidies to buy private insurance would reduce overall savings. The Wall Street Journal (11/26) LinkedInFacebookTwitterEmail this Story
  • N.J. considers bill to allow NPs to prescribe on their own
    New Jersey state Sen. Joseph Vitale, D-Middlesex, has introduced a bill that would give advanced practice registered nurses the power to prescribe drugs independently, eliminating the need for a formal agreement with a consulting physician. Supporters said the bill would help address the shortage of primary care providers in the state, which is expected to get worse once the Affordable Care Act is fully implemented. NJSpotlight.com (New Jersey) (11/26) LinkedInFacebookTwitterEmail this Story
  Drug Industry Spotlight 
  • Reminders increase statin adherence in study
    Patients who received automated phone calls and follow-up letters were more likely to fill initial prescriptions for statins than those who did not receive reminders, according to a study of 5,216 patients who did not fill their new prescriptions within two weeks. Patients whose insurance plans included a drug benefit were more likely to fill prescriptions, the researchers found. MedPage Today (free registration) (11/26) LinkedInFacebookTwitterEmail this Story
  SmartQuote 
Every path hath a puddle."
--George Herbert,
Welsh-British poet, orator and priest


LinkedInFacebookTwitter

 
 
Subscriber Tools
     
Print friendly format | Web version | Search past news | Archive | Privacy policy

 
Contact PCMA
Charles Cote
Assistant Vice President, Strategic Communications
(202) 207-3610

Twitter  Follow PCMA on Twitter
 
About PCMA
PCMA is the national association representing America's pharmacy benefit managers (PBMs), which administer prescription drug plans for more than 210 million Americans with health coverage provided through Fortune 500 employers, health insurance plans, labor unions, and Medicare Part D. PCMA is dedicated to enhancing the proven tools and techniques pioneered by PBMs that generate savings and access for consumers and payors.

 
 Recent PCMA SmartBrief Issues:   Lead Editor:  Melissa Turner
     
Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
 
 
© 1999-2012 SmartBrief, Inc.® Legal Information